Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results

Saag, Kenneth G.; Devogelaer, Jean-Pierre; Zanchetta, Jose R.; Adler, Robert A.; Eastell, Richard; See, Kyoungah; Dalsky, Gail P.; Krohn, Kelly; Krege, John H.; Warner, Margaret R.

doi:10.1002/art.23374

Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results

Saag, Kenneth G.

;

Devogelaer, Jean-Pierre

;

Zanchetta, Jose R.

;

Adler, Robert A.

;

Warner, Margaret R.

;et.al.

(2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: San Francisco (Ca) (24.October.2008)

Files

pdfdocument.pdf

Restricted Access
Adobe PDF
96.29 KB

Request a copy

Details

Authors

Saag, Kenneth G.
Author
Devogelaer, Jean-PierreUCLouvain
Author
Zanchetta, Jose R.
Author
Adler, Robert A.
Author
Warner, Margaret R.
Author

Affiliations

Citations

APA
Chicago
FWB

Saag, K. G., Devogelaer, J.-P., Zanchetta, J. R., Adler, R. A., Eastell, R., See, K., Dalsky, G. P., Krohn, K., Krege, J. H., & Warner, M. R. (2008). Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results. Arthritis & Rheumatism, 58(9), S939-S939. https://doi.org/10.1002/art.23374 (Original work published 2008)